Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour.
about
Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and diseaseNecrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.Anti-diabetic efficacy and impact on amino acid metabolism of GRA1, a novel small-molecule glucagon receptor antagonistPancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advancesGlucagon receptor gene mutations with hyperglucagonemia but without the glucagonoma syndrome.ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndromeVascular pancreatic lesions: spectrum of imaging findings of malignant masses and mimics with pathologic correlation.Nutrient regulation of glucagon secretion: involvement in metabolism and diabetes.Glucagon: acute actions on hepatic metabolism.Glucagonoma syndrome: a review and update on treatment.Rare diseases in clinical endocrinology: a taxonomic classification system.Management of the hormonal syndrome of neuroendocrine tumors.Glucagonoma syndrome with serous oligocystic adenoma: A rare case report.Glucagonoma and the glucagonoma syndrome.Malignant transformation of glucagonoma with SPECT/CT In-111 OctreoScan features: A case report.Emergency pancreatic resection for glucagonoma associated with severe necrolytic migratory erythema.Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.Glucagonoma syndrome: A case report.Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
P2860
Q27027920-044E1E8A-C4E1-4B29-9207-E77B383F9599Q33927124-1C308EF6-5A79-4B7B-8D2A-D519AA23CCD1Q34490178-ECDDA0F3-988E-44B6-913A-6AFB7308192CQ34650411-0B4ECE52-28B0-40B7-B2FF-C1E193839606Q35334364-AB919AED-7F33-4FE2-96EA-5B804E955314Q36849357-E513D18B-73CC-4FE2-8114-F9D4705AB7BDQ37231446-1289E222-74B9-4327-BB36-6D2BBE81E6D9Q38042556-37DBF6A9-BE17-4132-A3CC-50C0AA07F47AQ38203645-876C2854-1093-40C4-8AB7-DDD1CEEEA1A0Q38817842-7817369B-18E8-420A-ADD7-09B27DDC6896Q38898616-E5FB3566-CBBB-4788-BFD4-067259273FBBQ39102141-D6C7E78C-B61B-4D02-BC78-4483B6AEAC44Q41832570-868A79A1-DCDF-4141-BAF8-78F2AD276789Q46050819-D99956C0-51E1-4901-A8D0-6D8418A8BF81Q49471166-1F7CE77A-DBC3-4275-A2D5-264AA644D526Q49487400-CE4CA7A6-6625-4E70-8FE0-7F5BB8CC7A80Q49576212-5F97A555-A3BC-4400-8198-2BAC77F16E30Q53422328-6574C1C9-FEF1-4527-A572-5955E7589E10Q53807811-7ACACCA7-B2EF-4AE8-BD53-2E2821A31DEFQ53833734-4D80FF69-8534-4886-A081-78F374C65635
P2860
Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Glucagonoma and the glucagonom ...... h an elusive endocrine tumour.
@en
Glucagonoma and the glucagonom ...... h an elusive endocrine tumour.
@nl
type
label
Glucagonoma and the glucagonom ...... h an elusive endocrine tumour.
@en
Glucagonoma and the glucagonom ...... h an elusive endocrine tumour.
@nl
prefLabel
Glucagonoma and the glucagonom ...... h an elusive endocrine tumour.
@en
Glucagonoma and the glucagonom ...... h an elusive endocrine tumour.
@nl
P2093
P2860
P1476
Glucagonoma and the glucagonom ...... th an elusive endocrine tumour
@en
P2093
Asher Salmon
David J Gross
Merav Fraenkel
Victoria Doviner
P2860
P304
P356
10.1111/J.1365-2265.2011.03967.X
P577
2011-05-01T00:00:00Z